Diagnosis and Management of Cryptorchidism

被引:13
作者
Comploj, Evi [1 ]
Pycha, Armin [1 ]
机构
[1] Cent Hosp Bolzano, Dept Urol, Bolzano, Italy
关键词
Cryptorchidism; Therapy; Undescended testis; POSTNATAL TESTICULAR MALDEVELOPMENT; MULLERIAN DUCT SYNDROME; HORMONE-LEVELS; LAPAROSCOPIC EVALUATION; EPIDIDYMAL ANOMALIES; UNDESCENDED TESTES; NONPALPABLE TESTIS; ORCHIOPEXY; FERTILITY; THERAPY;
D O I
10.1016/j.eursup.2012.01.005
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
100201 [内科学]; 100221 [泌尿外科学];
摘要
Among males born at full term or prematurely, 1-30% are affected by cryptorchidism. Approximately 70% of cryptorchid testes will spontaneously descend by 3 mo. The cause of cryptorchidism is multifactorial. A prerequisite for testicular descent is a normal hypothalamic-pituitary-gonadal axis. In addition, an undisturbed interaction with the anatomic structures is required, as well as the appropriate hormonal milieu and environmental conditions. Hereditary factors also play a major role. The Kaplan classification distinguishes between palpable testes (80%) and nonpalpable testes (20%). The nonpalpable group includes intra-abdominal, inguinal, and absent (vanishing) testes, whereas palpable testes can be between the internal and external inguinal ring, high scrotal, or in a superficial pouch between the oblique and the Scarpa fascia in the so-called Denis Browne pouch. Therapy for undescended testis (UDT) is usually carried out when a child is between 6 and 12 mo; individuals with high UDT especially benefit from an early orchidopexy. The lower the pretreatment position, the more chance there is of spontaneous descent as well as better results of surgical intervention. Although the management of a palpable testis is standardized, there are no guidelines for the management of boys with a nonpalpable testis. It seems that both preoperative and postoperative hormonal treatment may have a beneficial effect on fertility later in life. Because of the increased risk of testicular malignancy, lifelong follow-up is mandatory. (C) 2012 European Association of Urology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:2 / 9
页数:8
相关论文
共 92 条
[1]
TESTICULAR CANCER AND CRYPTORCHIDISM [J].
ABRATT, RP ;
REDDI, VB ;
SAREMBOCK, LA .
BRITISH JOURNAL OF UROLOGY, 1992, 70 (06) :656-659
[2]
The descriptive epidemiology of congenital and acquired cryptorchidism in a UK infant cohort [J].
Acerini, C. L. ;
Miles, H. L. ;
Dunger, D. B. ;
Ong, K. K. ;
Hughes, I. A. .
ARCHIVES OF DISEASE IN CHILDHOOD, 2009, 94 (11) :868-872
[3]
BAIKIE G, 1990, PEDIATR SURG INT, V5, P458
[4]
A multi-institutional analysis of laparoscopic orchidopexy [J].
Baker, LA ;
Docimo, SG ;
Surer, I ;
Peters, C ;
Cisek, L ;
Diamond, DA ;
Caldamone, A ;
Koyle, M ;
Strand, W ;
Moore, R ;
Mevorach, R ;
Brady, J ;
Jordan, G ;
Erhard, M ;
Franco, I .
BJU INTERNATIONAL, 2001, 87 (06) :484-489
[5]
Bakr A A, 1998, JSLS, V2, P259
[6]
Association of epididymal anomalies with patent processus vaginalis in hernia, hydrocele and cryptorchidism [J].
Barthold, JS ;
Redman, JF .
JOURNAL OF UROLOGY, 1996, 156 (06) :2054-2056
[7]
LACK OF FEMINIZATION OF THE CREMASTER NUCLEUS IN CRYPTORCHID ANDROGEN INSENSITIVE RATS [J].
BARTHOLD, JS ;
MAHLER, HR ;
NEWTON, BW .
JOURNAL OF UROLOGY, 1994, 152 (06) :2280-2286
[8]
CRYPTORCHIDISM AND TESTICULAR CANCER [J].
BATATA, MA ;
WHITMORE, WF ;
CHU, FCH ;
HILARIS, BS ;
LOH, J ;
GRABSTALD, H ;
GOLBEY, R .
JOURNAL OF UROLOGY, 1980, 124 (03) :382-387
[9]
BERKOWITZ GS, 1993, PEDIATRICS, V92, P44
[10]
MATERNAL HORMONE LEVELS IN EARLY GESTATION OF CRYPTORCHID MALES - A CASE-CONTROL STUDY [J].
BERNSTEIN, L ;
PIKE, MC ;
DEPUE, RH ;
ROSS, RK ;
MOORE, JW ;
HENDERSON, BE .
BRITISH JOURNAL OF CANCER, 1988, 58 (03) :379-381